Use of Recombinant Factor VIIa (NovoSeven®) to Reduce Postoperative Bleeding after Total Hip Arthroplasty in a Patient with Cirrhosis and Thrombocytopenia
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 96 (6) , 1525-1527
- https://doi.org/10.1097/00000542-200206000-00040
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: